These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33067316)

  • 1. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.
    Ziogas DC; Kostantinou F; Cholongitas E; Anastasopoulou A; Diamantopoulos P; Haanen J; Gogas H
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma.
    Lee PC; Chao Y; Chen MH; Lan KH; Lee IC; Hou MC; Huang YH
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32863270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
    Yazici O; Sendur MA; Aksoy S
    World J Gastroenterol; 2014 Jun; 20(22):6716-24. PubMed ID: 24944464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B reactivation and immune check point inhibitors.
    Godbert B; Petitpain N; Lopez A; Nisse YE; Gillet P
    Dig Liver Dis; 2021 Apr; 53(4):452-455. PubMed ID: 32921602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of autoimmune and viral hepatitis in immunotherapy: a narrative review.
    Kuo L; Kuwelker S; Tsai E
    Ann Palliat Med; 2023 Nov; 12(6):1275-1294. PubMed ID: 37731304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
    Snast I; Atzmony L; Braun M; Hodak E; Pavlovsky L
    J Am Acad Dermatol; 2017 Jul; 77(1):88-97.e5. PubMed ID: 28495497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
    Khera L; Paul C; Kaul R
    Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate.
    Aceituno L; Bañares J; Ruiz-Ortega L; Callejo-Pérez A; Muñoz-Couselo E; Ortiz-Velez C; Díaz-Mejía N; Barreira-Díaz A; Carreras MJ; Farriols A; Buti M; Riveiro-Barciela M
    Front Med (Lausanne); 2022; 9():916213. PubMed ID: 35911389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
    Tomova R; Antonov K; Ivanova A; Jacobs JJ; Koten JW; Den Otter W; Krastev Z
    Anticancer Res; 2009 Dec; 29(12):5241-4. PubMed ID: 20044643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
    Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ
    Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
    Piaserico S; Messina F; Russo FP
    Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV).
    Pisaturo M; Macera M; Alessio L; Calò F; Coppola N
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection.
    Pertejo-Fernandez A; Ricciuti B; Hammond SP; Marty FM; Recondo G; Rangachari D; Costa DB; Awad MM
    Lung Cancer; 2020 Jul; 145():181-185. PubMed ID: 32423643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence.
    Tapia Rico G; Chan MM; Loo KF
    Cancer Treat Rev; 2020 Jun; 86():102011. PubMed ID: 32213376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
    Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
    Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV/HCV Coinfection in the Era of HCV-DAAs.
    Abdelaal R; Yanny B; El Kabany M
    Clin Liver Dis; 2019 Aug; 23(3):463-472. PubMed ID: 31266620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.